BioCentury | Apr 20, 2017
Product R&D
Stalling translation
...of PCSK9 in preclinical development that were out-licensed to an undisclosed company last year, and Liphorus Pharmaceuticals Inc....
...NASDAQ:AMGN), Thousand Oaks, Calif. Arrakis Therapeutics Inc., Waltham, Mass. Genentech Inc., South San Francisco, Calif. Liphorus Pharmaceuticals Inc....
...NASDAQ:AMGN), Thousand Oaks, Calif. Arrakis Therapeutics Inc., Waltham, Mass. Genentech Inc., South San Francisco, Calif. Liphorus Pharmaceuticals Inc....